Anterra Capital Reaches $100M First Close for Fund III to Back AI in the $10T Food Industry
The agrifoodtech sector has experienced a significant reset in funding, with global venture capital investment peaking at $51.7 billion in 2021 and falling to $16 billion by 2025. This decline presents a prime entry point for investment, as Anterra Capital has identified. The specialist food and agriculture venture firm is well-positioned to capitalize on the growing demand for innovative solutions in the industry, leveraging its expertise in building and backing companies from scratch.
ANALYSIS (continued): Fund III's first two investments, Anchr and Animerra, demonstrate Anterra's focus on AI-driven solutions and in-house company creation. The firm's reliance on a venture-partner and LP network rather than headcount also suggests a strategic approach to amplifying its reach without expanding its team. As Anterra Capital continues to build its portfolio, it will be interesting to see how its investments in AI and agrifoodtech evolve and impact the industry.
Key Takeaways
Anterra Capital's $100 million first close for Fund III marks a significant milestone in the agrifoodtech sector, highlighting the growing interest in AI-driven solutions.
The firm's in-house company creation model, as seen with Animerra, may become a key differentiator in the venture capital landscape.
The success of Anchr and Enko Chem will be closely watched, as they represent two distinct approaches to leveraging AI in agrifoodtech.
About the Source
This analysis is based on reporting by HackerNoon. Here is a short excerpt for context:
Anterra Capital announced a $100 million first close on Fund III in June 2026, targeting $200 million, with backing from Rabobank, Novo Holdings, and Zoetis among others. Anterra Capital is a specialist food and agriculture venture firm founded in Amsterdam in 2013, with offices in Amsterdam and Boston, managing over $500 million across three funds. Anterra builds companies from scratch in addition to backing them; its company creation Invetx was founded in 2018 and sold to Dechra Pharmaceuticals for up to $520 million within six years. Anterra's company creation Enko Chem, founded in 2017, develops new crop protection chemistry to replace glyphosate, with research partnerships with Bayer and Syngenta. Global agrifoodtech venture funding peaked at $51.7 billion in 2021 before falling to roughly $16 billion by 2025, a reset to 2016 levels that Anterra calls the most attractive entry point in twelve years. Fund III's first two investments are Anchr, an AI-native food distribution platform backed alongside a16z Speedrun, and Animerra, a veterinary biologics company Anterra founded and built in-house. Anterra operates with 11 full-time employees and 4 partners, relying on a venture-partner and LP network rather than headcount to extend its reach.Read the original at HackerNoon
